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Abstract  19 
Purpose Previously in 1987, a 21-year-old-male was diagnosed with primary 20 
hyperparathyroidism (PHPT) when a right inferior parathyroid adenoma was removed. PHPT 21 
recurred after three and six years and on both occasions was cured by resection of parathyroid 22 
adenomas. At 52-years-of-age, the patient developed a late-onset hypoparathyroidism (HP), 23 
even though postsurgical HP typically occurs as a transient or permanent form soon after neck 24 
surgery. The purpose of this work was to report the follow-up of the patient and to review prior 25 
cases of late-onset postsurgical HP. 26 
Methods Prior cases of late-onset postsurgical HP were searched and reviewed focusing on 27 
clinical and biochemical features. 28 
Results The patient’s asymptomatic hypocalcemia with total serum calcium at 8.2 mg/dL was 29 
initially documented in September 2018; PTH was inappropriately low at 15 ng/mL. In 30 
February 2020, a mild hypocalcemia was confirmed with low-normal PTH at 15 ng/mL. 31 
Autoimmune and familial causes of HP were ruled out including the presence of stimulating 32 
autoantibodies against calcium-sensing receptor. Instead, a progressive damage or atrophy of 33 
the parathyroid gland(s) ensuing years after surgery is believed to have led to the patient’s 34 
hypocalcemia. All 19 previously reported cases of late-onset postsurgical HP occurred after 35 
thyroid surgery, with no examples of the condition being found following parathyroidectomy. 36 
Conclusions The case highlights the rare occurrence of late-onset postsurgical HP in a patient 37 
who had had multiple parathyroidectomies for PHPT. Thus, monitoring serum calcium, 38 
phosphate and PTH during follow-up of such patients is recommended. 39 




































































Introduction  41 
Postsurgical hypoparathyroidism (HP) may occur after total thyroidectomy or radical neck 42 
dissection and is caused by inadvertent removal of parathyroid glands and/or the irreversible 43 
damage of their blood supply [1, 2]. The resulting reduced or absent production of PTH leads 44 
to hypocalcemia either because of the lack of mobilization of calcium and phosphate from the 45 
skeleton or synthesis of calcitriol due to impaired or absent renal hydroxylation of serum 25-46 
hydroxyvitamin D [1]. In addition, reduced PTH lowers reabsorption of calcium and secretion 47 
of phosphate in renal tubular cells. Postsurgical HP may occur transiently when hypocalcemia 48 
persists for less than six months or permanently when hypocalcemia persists for more than six 49 
and upto 12 months after surgery in the presence of low or inappropriately normal PTH levels 50 
[1, 2].  51 
Transient hypocalcemia is not uncommon in the post-operative period after parathyroidectomy 52 
in patients with primary hyperparathyroidism (PHPT) caused by the delayed functional 53 
recovery of the remaining parathyroid glands and the inhibition of PTH secretion by prior 54 
hypercalcemia [2, 3]. The biochemical signature is also characterized by high or elevated serum 55 
phopshate and low or undetectable PTH. Another form of hypocalcemia, the so-called hungry 56 
bone syndrome, may follow parathyroidectomy, mainly in patients with severe PHPT and 57 
preoperative high bone turnover, due to rapid remineralization of bone [4]. 58 
Parathyroidectomy usually rapidly decreases bone resorption. However, in hungry bone 59 
syndrome, the rate of bone formation remains elevated for several weeks, with increased 60 
calcium influx in bone and the development of persistent hypocalcemia that requires treatment 61 
with calcium and active vitamin D [4]. In these patients, the biochemical signature is also 62 




































































Late-onset postsurgical HP is a rare condition which has been shown to develop several years 64 
after thyroid surgery [3, 5–18]. Symptoms of hypocalcemia may be latent and mild and very 65 
rarely sever [3, 5, 11–13]. The underlying mechanism of the late-onset postsurgical HP is 66 
unclear and may be due to progressive damage or atrophy of the parathyroid glands leading to 67 
their insufficiency years after surgery. To our knowledge, no case of late-onset postsurgical HP 68 
has been described so far in patients with PHPT after parathyroidectomy.  69 
Herein, the follow-up is described of a patient with apparently sporadic recurrent PHPT 70 
carrying a germline mutation of the CDC73 gene who had undergone three subsequent 71 
parathyroidectomies with resection of four parathyroid adenomas [19]. Over time, the patient 72 
gradually developed a late-onset postsurgical HP. Prior cases of late-onset postsurgical HP, 73 
with particular focus on the clinical and biochemical features of this rare condition, are also 74 




































































Materials and Methods 76 
Patient history 77 
The detailed medical history of the patient has been reported in a prior publication [19]. The 78 
relevant clinical details are briefly reported here. The patient was first diagnosed with PHPT in 79 
1987 at the age of 21 years with a total serum calcium of 17.3 mg/dL (normal range, 8.6-10.2 80 
mg/dL) and a C-PTH level of 3.17 ng/mL (normal, <0.88 ng/mL). In the same year, the patient 81 
underwent right inferior parathyroidectomy. In 1990, a relapse of PHPT was diagnosed and 82 
successfully cured in 1993 by right superior parathyroidectomy. The patient was referred to 83 
our outpatient clinic in 1998 for recurrent PHPT. His total serum calcium and PTH were mildly 84 
elevated at 10.6 mg/dL and 72 ng/L (normal range, 10–65 ng/L), respectively. In March 2004, 85 
a further relapse of PHPT was evident. The patient’s total and ionized serum calcium were 12.2 86 
mg/dL and 1.75 mmol/L (normal range, 1.12-1.32 mmol/L), respectively, and a PTH level of 87 
260 ng/L. The patient underwent surgical neck exploration and subsequent superior and inferior 88 
left parathyroidectomy. Histological examination of the excised parathyroids showed chief cell 89 
adenomas. Subsequent genetic analysis identified a germline mutation of the CDC73 gene 90 
(encodes the tumor supressor parafibromin) in exon 3 (R91P), and the loss of parafibromin 91 
expression was implicated in the development of the benign parathyroid tumors. Following 92 
the identification of the CDC73 gene mutation which are responsible for 93 
hyperparathyroidism-jaw tumor syndrome, a re-evaluation of all parathyroid 94 
histological sections was carried out by our pathologist in order to exclude atypical or 95 
malignant features that can be present in this setting [20]. However, histology did not 96 
reveal the presence of atypical features (i.e solid growth pattern, fibrous bands and 97 




































































Furthermore, since patients carrying CDC73 mutations might develop 99 
mandibular/maxillary fibrous tumors and kidney tumors, a radiologic evaluation of the 100 
jaw and an abdomen ultrasound were undertaken, but these excluded the presence of tumor 101 
lesions. Following the final parathyroidectomy, the patient had a transient hypocalcemia after 102 
which ionized serum calcium remained within the normal range until March 2006 (Table 1). 103 
PTH also remained within the normal range except for a slight elevation to 68 ng/L in March 104 
2005 (Table 1). 105 
Calcium-sensing receptor (CaSR) immunoprecipitation assays 106 
Immunoprecipitation assays used to detect CaSR antibodies were undertaken as detailed 107 
elsewhere [21]. Briefly, HEK293 cells were transiently transfected with pcCaSR-FLAG. 108 
GammaBind® Sepharose beads (50-µl samples) (GE Healthcare, Little Chalfont, UK) were 109 
mixed with sera at a 1:100 dilution and incubated at 4°C for 1 h. The beads and IgG complexes 110 
were collected and incubated with cell extract containing CaSR-FLAG protein for 16 h at 4°C, 111 
then collected and subjected to SDS-PAGE and immunoblotting using anti-FLAG® M2-112 
Peroxidase Conjugate (Sigma-Aldrich, Poole, UK) and an ECL™ Western Blotting Analysis 113 
System (GE Healthcare). The densitometry of bands was performed in a Bio-Rad GS 690 114 
Scanning Densitometer with Multi-Analyst Software (Bio-Rad Laboratories Ltd., Hemel 115 
Hempstead, UK). A CaSR antibody index for each serum sample was calculated as the 116 
densitometry value of the tested serum/mean densitometry value of 10 control sera. The upper 117 
normal limit for the assay was calculated using the mean CaSR antibody index + 3 SD of 10 118 
controls and was a value of 2.78. 119 
 120 




































































A systematic Pubmed search focused on late-onset postsurgical HP was undertaken. The 122 
following keywords were used for the search:  “late-onset hypoparathyroidism”, “late-onset 123 
hypocalcemia”, “post surgical hypoparathyroidism”, “post surgical hypocalcemia”, “delayed 124 
hypoparathyroidism”, “post thyroidectomy hypoparathyroidism”, “post parathyroidectomy 125 
hypocalcemia”, “iatrogenic hypoparathyroidism”, and “post thyroidectomy basal ganglia 126 
calcifications”. The search was made with and without the filter “case reports”. All eligible 127 
studies were retrieved and their references checked for further relevant articles. 128 
 129 





































































Case follow-up 132 
Since CDC73 mutation carriers are at risk for recurrence of PHPT or parathyroid cancer, 133 
regular follow-up was mandatory in this patient. Frequent surveillance may allow an early 134 
detection and cure of PHPT, before a possible development of malignancy [19]. 135 
Between March 2006 and July 2008, a relapse of the patient’s PHPT was suspected because of 136 
the finding that at yearly evaluation there was a slightly elevated ionized serum calcium 137 
associated with PTH levels at the upper limit of the normal range (Table 1). No kidney stones 138 
or nephrocalcinosis were present. Bone mineral density confirmed a reduced bone mass at one-139 
third distal radius which was comparable with that found in 2004. Neck ultrasound and a 140 
sestamibi scan were negative. In May 2009, the patient was further evaluated, and at this time 141 
total and ionized serum calcium and PTH, as well as  24-h urinary calcium (normal range, 100-142 
300 mg/24-h), were within the normal ranges. The subsequent follow-ups were notable for the 143 
progressive reduction, although still in the normal range, of total and ionized serum calcium 144 
and PTH levels (Table 1). 145 
In September 2018, the patient was in good health and asymptomatic. The patient’s recent 146 
medical history was notable for the presence of arterial hypertension for which he was taking 147 
zofenopril. The patient was also taking cholecalciferol (25,000 IU monthly). Physical 148 
examination was negative except the presence of neck scars. Chvostek and Trousseau signs 149 
were negative. Total serum and ionized calcium were low at 8.2 mg/dL and 1.07 mmol/L, 150 
respectively (Figure 1). PTH was inappropriately low-normal at 15 ng/L (Figure 1). Serum 151 
phosphate at 2.9 mg/dL (normal range, 2.5-4.5 mg/dL), magnesium at 2.1 mg/dL (normal 152 
range, 1.7-2.2 mg/dL), creatinine at 1.11. mg/dL (normal range, 0.5 to 1.2 mg/dL), and urinary 153 




































































ng/mL (normal range, 20-50 ng/mL). Alkaline phosphatase and liver function tests were 155 
normal. Neck and abdomen ultrasounds did not reveal any tumor lesions. No autoimmune 156 
disorders were present. Given that there was no evidence of any other disease contributing to 157 
the patient’s hypocalcemia, and no family history of HP, a diagnosis of postsurgical HP was 158 
made. Since symptoms and signs of hypocalcemia were absent, no treatment was advised. 159 
In February 2020, laboratory tests confirmed a mild hypocalcemia. Total serum and ionized 160 
calcium were low at 7.9 mg/dL and 0.98 mmol/L, respectively (Figure 1). PTH levels were 161 
inappropriately low-normal at 15 ng/L (Figure 1). Serum phosphate and magnesium were 162 
normal at 3.8 mg/dL and 2.0 mg/dL, respectively. Urinary calcium was normal 102 mg/24-h. 163 
Renal function was also normal. Serum 25-hydroxyvitamin D was normal at 39 ng/mL while 164 
receiving cholecalciferol (25,000 IU monthly). Electrocardiogram (ECG) did not show 165 
prolongation of QT interval. Abdomen ultrasound was negative for kidney stones and 166 
nephrocalcinosis. Chest x-ray was normal. No hyperparathyroidism-jaw tumor syndrome-167 
related tumors were present. The patient was in good health and had no symptoms or signs of 168 
hypocalcemia, thus, no specific treatment was advised. 169 
CaSR autoantibody analysis 170 
Normally, the CaSR controls serum calcium levels via PTH secretion from the parathyroid 171 
keeping the calcium concentration within a very tight range. In rare cases autoantibodies 172 
against the receptor can cause primary hypoparathyroidism [21]. In such cases, CaSR 173 
autoantibodies stimulate the receptor so that even at lower than optimum calcium levels PTH 174 
secretion from the parathyroid glands is reduced. However, the patient was negative for CaSR 175 





































































Review of the literature for postsurgical HP 178 
A total of 19 relevant articles were retrieved for systematic review. Four were excluded due to 179 
the lack of a full-text article, so that 15 studies were included and reviewed [3, 5–18]. The 180 
results are in Table 2. All cases of late-onset postsurgical HP occurred after thyroid surgery, 181 
with no examples of the condition being found following parathyroidectomy. 182 





































































Acquired HP is usually caused by inadvertent removal of the parathyroid glands or damage of 185 
their blood supply during thyroid surgery. Indeed, postsurgical HP is the most common 186 
complication of total or near-total thyroidectomy [2]. More rarely, it can be caused by the 187 
excision of too much parathyroid tissue during surgery for PHPT. Other rare causes include 188 
hemochromathosis, sarcoidosis, emosiderosis, Wilson’s disease, and metastatic infiltration of 189 
the parathyroid gland [1].  190 
Given the clinical history of the patient who carried a germline mutation of the CDC73 gene 191 
leading to recurrent PHPT [19], we unexpectedly observed a late-onset postsurgical HP rather 192 
than a possible and foreseeable recurrence of PHPT. Of note, three years after the last 193 
parathyroidectomy, leading to completion of (sub)total parathyroidectomy, a slight increase 194 
of ionized serum calcium and inappropriately normal PTH levels were observed in the absence 195 
of enlarged parathyroid gland(s) at neck imaging. This biochemical picture raised the suspicion 196 
for a further recurrence of PHPT supporting the concept that, in this setting, all parathyroid 197 
tissue may continue to proliferate overtime [1, 19]. However, a subsequent normocalcemia was 198 
evident. The former and latter findings were consistent with the presence of a 199 
supernumerary parathyroid gland. Otherwise, it could be speculated that the patient 200 
might have a small amount of malignant parathyroid tissue in the site of the first surgery 201 
which was carried-out elsewhere and not-re-explored at the last surgery able to maintain 202 
normocalcemia. However, the revision of all histological sections of the right-side tumors 203 
by our pathologist showed no histological features of malignancy [19]. Thus, we can 204 
speculate that the function of the supernumerary parathyroid gland remained almost 205 
normal for a given period of time and then progressively decreased due to its damage or 206 
atrophy. The question of whether other factors (i.e. environmental) might have 207 




































































However, during follow-up, serum calcium slowly decreased over the years until a mild 209 
asymptomatic hypocalcemia with inappropriately low-normal PTH levels was evident. 210 
Potential causes of hypocalcemia including hypomagnesemia were ruled out; the patient did 211 
not have autoimmune disorders or a family history of autoimmunity [22], family members did 212 
not have a history of hypocalcemia ruling out a genetic cause [23], and the patient was negative 213 
for autoantibodies to the CaSR [21, 22], a molecule that controls serum calcium levels via PTH 214 
secretion from the parathyroid gland. When HP gradually develops, as in non-surgical acquired 215 
forms, patients are usually asymptomatic, reflecting a sort of adaptation to a progressive decline 216 
of serum calcium [2, 18]. In line with this, our patient did not experience symptoms or signs of 217 
hypocalcemia over the years, so we suggest that the residual parathyroid gland, which kept the 218 
patient normocalcemic for 14 years, underwent progressive damage until HP developed.  219 
To date, 19 cases of late-onset postsurgical HP have been reported and all occurred after thyroid 220 
surgery [3, 5–18]. The first case was described in 1962 by Blanchard et al. who described a 59-221 
year-old male patient presenting with hypocalcemia 33 years after thyroidectomy [5]. This 222 
patient was admitted to the University Hospital because of “jerking of his right arm and leg” 223 
and a recent history of seizures. Laboratory tests showed a severe hypocalcemia and 224 
hyperphosphatemia. ECG showed QT-interval prolongation. At the time of hospital admission 225 
focal seizures occurred every 15 minutes and they disappeared after one day of intravenously 226 
calcium therapy. 227 
Eighteen patients with late-onset postsurgical HP have since been reported. Four occurred after 228 
subtotal thyroidectomy and 15 after total thyroidectomy (Table 2). The age at diagnosis varied 229 
considerably from nine months to 41 years with a higher prevalence in females than males (15 230 
vs 4), an expected figure considering that thyroid disease is more prevalent in the former. In 231 




































































30.8  5.81 years (range, 23-41 years) [5–8, 10, 12, 13, 15, 18]. In the remaining nine patients, 233 
HP was evident within 20 years of surgery with a mean time of 10.1  7.44 years (range, nine 234 
months-19 years) [3, 9, 11, 12, 14, 16, 17]. The mean age at diagnosis was 54.5  13.8 years 235 
(range, 24-76 years). In female patients, this was 54.5  14.62 years (range, 24-76 years) and, 236 
in males, 54.2  12.14 years (range, 42-69 years). 237 
Ten of 19 (52.6%) patients experienced severe symptoms of hypocalcemia that required 238 
hospitalization. The medical history of these patients was characterized by seizures which were 239 
evident for many years or just a few months [11–14, 17, 18]. Conversely, four of the 19 (21.1%) 240 
patients had a history of cramps or tingling in the limbs. In the remaining cases, the medical 241 
history was not available. Finally, in six cases (31.6%), computed tomography (CT) scans 242 
showed the presence of bilateral and extended brain calcifications, that in HP are located most 243 
often in basal ganglia. Patients with brain calcifications usually had a late diagnosis after 244 
surgery (range, 10-41 years). 245 
In conclusion, this case highlights the rare occurrence of late-onset postsurgical HP in a patient 246 
who had had multiple parathyroidectomies for PHPT as well as in patients with previous 247 
thyroidectomy, particularly if total. Although hypocalcemia typically occurs in the immediate 248 
postoperative period, progressive damage or atrophy of the parathyroid gland(s) may ensue 249 
years after surgery leading to blood calcium and PTH insufficiency. Thus, serum calcium, 250 
phosphate and PTH should be monitored during follow-up in patients who have had previous 251 
neck surgery to identify and eventually treat such patients. 252 
 253 
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Figure legend 344 
Fig. 1 Time-course of serum calcium and PTH concentrations in the patient. The normal range 345 
of serum calcium is 8.6-10.2 mg/dL. The normal range of PTH (2nd generation assay) is 10-65 346 

























































































Figure 1 Click here to access/download;Figure;Cetani Fig 1.tif
Table 1.  Biochemical findings of the patient.  
 















June 2004 1.23 na na 46 27.6 
March 2005 1.29 na na 68 21.3 
March 2006 1.34 na na 41 23.3 
July 2008 1.38 na na 65 31.9 
April 2009 na 9.6 2.2 46 20.6 
December 2009 1.22 na na 49 11.1 
December 2010 1.30 na na 47 22.4 
June 2012 1.18 9.1 2.8 22 25.1 
December 2014 1.19 9.3 3.0 21 43.3 
September 2016 1.17 9.0 3.5 17 47.6 
 
1Ionized serum calcium normal range: 1.12-1-32 mmol/L 
2Total serum calcium normal range: 8.6-10.2 mg/dL 
3Serum phosphorus normal range: 2.5-4.5 mg/dL 
4Plasma PTH normal range: 10-65 ng/L (2nd generation assay from June 2004 to October 2014); 8-40 ng/L 
(3rd generation assay from December 2014 to September 2016) 
5Serum 25-hydroxyvitamin D normal range: 20-50 ng/mL 





Table 2. Clinical and biochemical features of reported cases of late-onset postsurgical hypoparathyroidism.  
Reference Neck 
surgery1 











Blanchard et al. (5)  Tx  Jerking of right arm and leg 
 Seizures (clonic movements of the right hand that 
progressed to involve the entire right arm, trunk, and 
lower extremity) 
 Pursing and "smacking" of the lips 
 Tetany: not observed 
 Chvostek’s and Trousseau’s signs could not be elicited 




















Bull et al. (15) Subtotal Tx  Generalized seizures (tonic and clonic movements, eye 
rolling, tongue biting, and unconsciousness) 
 Frequent headaches and lassitude for years 
















Petch et al. (14) Tx (two 
operations) 
 Increasing forgetfulness 
 Loss of interest in her surroundings for several months 
 Fits 












Cox et al. (6) Tx  Episode of unconsciousness 
 Generalized seizure 
 Tetany: not observed 
 Chvostek: negative 




















Halperin et al. (7) Tx  Case 1: severe paresthesia and muscular spasm 
 
 Case 2: paresthesia and muscular spasm 
 
 Case 3: generalized seizures 
 
 








































Lang et al. (18) Tx  Tetany 
 Moderately demented 
 Bilateral symmetrical calcifications in both cerebellar 
hemispheres, mid-pons, white matter of the frontal, 
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Jorens et al (16) Subtotal Tx  History of generalized tonic-clonic seizures 
 Chvostek's and Trousseau's signs could not be elicited 
 Bilateral calcifications in the basal ganglia, thalami, 
frontal periventricular white matter, cerebellar 















Bellamy et al. (8) Tx  Four-year history of fatigue and musculoskeletal limb 
pains   
 History of seizures 
 Marked bilateral basal ganglia calcification  
 Increasing pain and stiffness in the neck, shoulders, 
back, arms and legs 





















Garg et al. (17) Tx  Generalized tonic-clonic seizure 
 Chovstek's and Trousseau's sign strongly positive 
 Extensive intracranial calcification of basal ganglia, 















Mrowka et al. (9) Subtotal Tx  Case 1: generalized tonic-clonic seizure 






















Adorni et al. (10) Tx  Progressive dementia 
 Psychosis, agitation and insomnia 







(normal range, na) 
 
< 1.0 
(normal range, na) 
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Zisimopoulou et al. 
(11) 
Tx  Loss of consciousness lasting a few seconds 
 Mild extrapyramidal signs 
 Extensive bilateral symmetrical brain calcifications in 
the frontal lobes, basal ganglia, subcortical and 


















Agarwal et al. (12) Tx  Generalized tonic-clonic convulsions     
 
1Tx, total thyroidectomy; PTx, parathyroidectomy 




 Tongue bite 
 Urinary incontinence 
 Trousseau and Chvostek signs positive 
 Truncal ataxia, dysdiadochokinesia, dysynergia, past 
pointing. Hypotonic limbs; diminished tendon reflexes 
















Kamath et al. (13) Tx  History of recurrent calf muscle cramps and aches in 
the legs 
 History of progressive forgetfulness, jitteriness, 
difficulty in walking, getting up from squatting 
position and rising from the chair, tingling and 
numbness in the hands, toes and around the mouth 
 Different episodes of generalized tonic-clonic seizures 
 Trousseau’s sign and Chovstek’s sign positive 
































Present study PTx  Asymptomatic 7.9 
(normal range, 
8.6-10.2) 
3.8 
(normal range, 
2.5-4.5) 
15 
(normal range, 8-
40) 
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